Literature DB >> 1314225

Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

L L Steed1, E T Akporiaye, R L Friedman.   

Abstract

Virulent Bordetella pertussis strains survive intracellularly within human polymorphonuclear leukocytes (PMN), at least in part because of inhibition of phagosome-lysosome fusion (L. L. Steed, M. Setareh, and R. L. Friedman, J. Leukocyte Biol. 50:321-330, 1991). Further investigations were done to determine if B. pertussis also inhibited respiratory burst activity of PMN as an additional mechanism of intracellular survival. Chemiluminescence and flow cytometry assays showed that B. pertussis induced significant levels of hydrogen peroxide production. In contrast, ferricytochrome c reduction showed that B. pertussis suppressed extracellular release of superoxide. PMN intracellular reduction of nitroblue tetrazolium verified that superoxide was indeed produced intracellularly during B. pertussis phagocytosis. Therefore, B. pertussis does not inhibit production of superoxide but inhibits only its release. Thus, while phagosome-lysosome fusion is inhibited by B. pertussis, respiratory burst activity of PMN occurs at normal levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314225      PMCID: PMC257121          DOI: 10.1128/iai.60.5.2101-2105.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Macrophage behaviour during the complaisant phase of murine pertussis.

Authors:  C Cheers; D F Gray
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

2.  Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils.

Authors:  C Dahlgren; H Aniansson; K E Magnusson
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

3.  Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.

Authors:  F F Craig; J M Lackie; R Parton; J H Freer
Journal:  J Gen Microbiol       Date:  1988-08

4.  Reduction of ferricytochrome C may underestimate superoxide production by monocytes.

Authors:  M J Arthur; P Kowalski-Saunders; S Gurney; R Tolcher; F G Bull; R Wright
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

5.  Histoplasma capsulatum fails to trigger release of superoxide from macrophages.

Authors:  L G Eissenberg; W E Goldman
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  The steady state in cellular immunity. II. Immunological complaisance in murine pertussis.

Authors:  D F Gray; C Cheers
Journal:  Aust J Exp Biol Med Sci       Date:  1967-08

7.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes.

Authors:  L K Riley; D C Robertson
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils.

Authors:  B L Beaman; C M Black; F Doughty; L Beaman
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  11 in total

1.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

3.  Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.

Authors:  A Banemann; R Gross
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Mechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells.

Authors:  C A Guzman; M Rohde; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica.

Authors:  B Schneider; R Gross; A Haas
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.

Authors:  Xuqing Zhang; Tania Goel; Laura L Goodfield; Sarah J Muse; Eric T Harvill
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

8.  Cloning and characterization of an Mn-containing superoxide dismutase (SodA) of Bordetella pertussis.

Authors:  H Graeff-Wohlleben; S Killat; A Banemann; N Guiso; R Gross
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

9.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps.

Authors:  Ladislav Bumba; Jiri Masin; Radovan Fiser; Peter Sebo
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.